Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cardiovascular Translational Research
Published in: Journal of Cardiovascular Translational Research 5/2020

01-10-2020 | Heart Failure | Correspondence

Differences in the Interleukin-1β/Soluble ST2 Interplay Between Acute and Chronic Heart Failure

Authors: E Revuelta-López, J Lupón, A Lax, DA Pascual-Figal, A Bayés-Genís

Published in: Journal of Cardiovascular Translational Research | Issue 5/2020

Login to get access

Abstract

Recently, novel findings about the interleukin 1β (IL-1 β) axis in acute decompensated heart failure (ADHF) have been published. There is a positive correlation between IL-1 β and interleukin-1 receptor like 1 (sST2) in ADHF patients. Is there also a correlation between the values of IL-1 β and sST2 in chronic heart failure patients?
Literature
1.
Haugen, E., Gan, L. M., Isic, A., Skommevik, T., & Fu, M. (2008). Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients. Experimental & Clinical Cardiology, 13(1), 19–24.
2.
Kosar, F., Aksoy, Y., Ozguntekin, G., Ozerol, I., & Varol, E. (2006). Relationship between cytokines and tumour markers in patients with chronic heart failure. European Journal of Heart Failure, 8(3), 270–274.CrossRef
3.
Pascual-Figal, D. A., Bayes-Genis, A., Asensio-Lopez, M. C., Hernández-Vicente, A., Garrido-Bravo, I., Pastor-Perez, F., Díez, J., Ibáñez, B., & Lax, A. (2019). The interleukin-1 axis and risk of death in patients with acutely decompensated heart failure. Journal of the American College of Cardiology, 73(9), 1016–1025.CrossRef
4.
Bayés-Genís, A., Núñez, J., & Lupón, J. (2017). Soluble ST2 for prognosis and monitoring in heart failure: the new gold standard? Journal of the American College of Cardiology, 70(19), 2389–2392.CrossRef
5.
Ridker, P. M., Everett, B. M., Thuren, T., et al. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. The New England Journal of Medicine, 377, 1119–1131.CrossRef
Metadata
Title
Differences in the Interleukin-1β/Soluble ST2 Interplay Between Acute and Chronic Heart Failure
Authors
E Revuelta-López
J Lupón
A Lax
DA Pascual-Figal
A Bayés-Genís
Publication date
01-10-2020
Publisher
Springer US
Published in
Journal of Cardiovascular Translational Research / Issue 5/2020
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-020-09958-7

Other articles of this Issue 5/2020

Journal of Cardiovascular Translational Research 5/2020 Go to the issue

Original Article

Lumped-Parameter Circuit Platform for Simulating Typical Cases of Pulmonary Hypertensions from Point of Hemodynamics

Original Article

Protein Thermodynamic Destabilization in the Assessment of Pathogenicity of a Variant of Uncertain Significance in Cardiac Myosin Binding Protein C

Original Article

Optimal ECG Lead System for Exercise Assessment of Ischemic Heart Disease

Correspondence

Heparin Administration, but Not Myocardial Ischemia or Necrosis, Leads to Midkine Elevation

Review

Exosomes: Cell-Free Therapy for Cardiovascular Diseases

Original Article

Myoglobin for Detection of High-Risk Patients with Acute Myocarditis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits